Spring 2021 Agenda

Friday, April 16, 2021

Please note all sessions are in Pacific Daylight Time (PDT)
7:00 AM - 8:00 AM PME or CME Symposium
8:00 AM - 8:30 AM Break

KEYNOTE ADDRESS

8:30 AM - 9:00 AM Keynote - Call To Action: Addressing The Disproportionate Burden & Disparities with COVID-19
Keith C. Ferdinand, MD
9:00 AM - 10:00 AM Keynote Panel Discussion - Roadblocks & Reflections: Looking for Solutions in a Time of Crisis
Moderator: Keith C. Ferdinand, MD
Panelists: Alanna A. Morris MD, MSc, FHFSA, FACC, FAHA

SESSION I: KIDNEY DISEASE/HEART FAILURE/HYPERTENSION

10:00 AM Chair Introduction
George L. Bakris, MD
10:00 AM - 11:30 AM CME Special Symposium
New Frontiers in Heart Failure Management
  1. The Changing Spectrum of HF: From HFrEF to HFmrEF to HFpEF - Assessing the Treatment Landscape
  2. Assessing The Data for HF Prevention and Treatment with SGLT-2 Inhibitors
    Stephen D. Wiviott, MD
  3. New and Emerging Treatment Targets in HF
  4. Predicting the Impact of These Advances: Updates in HF guidelines
    Clyde W. Yancy, MD, MSc, MACP
  5. HF Challenging Cases & Expert Panel Discussion
    Moderator: George L. Bakris, MD
    Panel: Stephen D. Wiviott, MD; Clyde W. Yancy, MD, MSc, MACP
11:30 AM - 12:00 PM Company Spotlight Break
12:00 PM - 1:00 PM PME Symposium
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc and Lilly USA, LLC.
1:00 PM - 1:30 PM Break
1:30 PM - 1:50 PM Evaluating Risk of CKD Progression
Joseph A. Vassalotti, MD
1:50 PM - 2:10 PM Updates in the Prevention and Treatment of CKD
Aldo J. Peixoto, MD
2:10 PM - 2:30 PM Primary Aldosteronism: An Underappreciated Issue in HTN
William F. Young, Jr., MD, MSc
2:30 PM - 3:00 PM DKD/HTN Challenging Cases & Expert Panel Discussion
Moderator: George L. Bakris, MD
Panel: Aldo J. Peixoto, MD; Ileana L. Piña, MD; Joseph A. Vassalotti, MD; William F. Young, Jr., MD, MSc
3:00 PM - 3:10 PM Break

SESSION II: DIABETES MANAGEMENT

3:10 PM - 3:15 PM Chair Introduction
Anne L. Peters, MD
3:15 PM - 3:35 PM Glycemic Management in Patients with CVD
Vanita Aroda, MD
3:35 PM - 3:55 PM Exercise as "Medicine" in the Treatment of T2DM
Jane Reusch, MD
3:55 PM - 4:15 PM Relationship Between TIR and Diabetes Complications
Nicholas B. Argento, MD, FACE
4:15 PM - 4:35 PM What is the Role of CGM in Prediabetes/Type 2 Diabetes?
Viral Shah, MD
4:35 PM - 5:05 PM Company Spotlight Break
5:05 PM - 5:25 PM Inpatient Use of CGM
Joseph A. Aloi, MD
5:25 PM - 5:45 PM Use of Insulin Pumps in the Management of T2DM
Grazia Aleppo, MD, FACE, FACP
5:45 PM - 6:15 PM Challenges Cases & Panel Discussions
Moderator: Anne L. Peters, MD
Panel: Joseph A. Aloi, MD; Grazia Aleppo, MD, FACE, FACP; Nicholas B. Argento, MD, FACE; Vanita Aroda, MD; Robert H. Eckel, MD; Jane Reusch, MD; Viral Shah, MD
6:15 PM Closing Remarks
Anne L. Peters, MD
6:15 PM - 6:45 PM Break
6:45 PM - 7:45 PM PME Symposium
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc and Lilly USA, LLC.

Saturday, April 17, 2021

Please note all sessions are in Pacific Daylight Time (PDT)
7:00 AM - 8:00 AM PME or CME Symposium
8:00 AM - 8:30 AM Break

SESSION III: OBESITY AND LIFESTYLE MEDICINE

8:30 AM - 8:35 AM Chair Introduction and Opening Remarks
Robert H. Eckel, MD
8:35 AM - 8:55 AM The Evolving Landscape of Obesity Management - A 2021 Update
Louis J. Aronne, MD
8:55 AM - 9:15 AM Practical Tips to Help Your Patients Succeed In Their Weight Loss Journey
Donna H. Ryan, MD
9:15 AM - 10:05 AM Challenges Cases & Panel Discussions - Practical Approaches to Weight Reduction
Moderator: Robert H. Eckel, MD
Panel: Louis J. Aronne, MD ; Donna H. Ryan, MD
10:05 AM - 10:35 AM Company Spotlight Break
10:35 AM - 11:20 AM Expert Perspectives - Best Approaches to Diets for Cardiometabolic Health
Kim A. Williams, Sr., MD; Penny M. Kris-Etherton, PhD; Sarah Hallberg, DO
11:20 AM - 12:05 PM Challenging Cases & Expert Panel Discussion
Moderator: Robert H. Eckel, MD
Panel: Penny M. Kris-Etherton, PhD; Sarah Hallberg, DO; Kim A. Williams, Sr., MD
12:05 PM - 12:10 PM Closing Remarks
Robert H. Eckel, MD
12:10 PM - 12:25 PM Break
12:25 PM - 1:25 PM CME Symposium
Antithrombotic Therapy for Symptomatic PAD: Interpreting the Evidence and Recent Advances

Chair: Deepak L. Bhatt, MD, MPH
Faculty: Marc P. Bonaca, MD, MPH; Manesh R. Patel, MD
Supported by an educational grant from Janssen Scientific Affairs, LLC. and AstraZeneca.
1:25 PM - 1:40 PM Break

SESSION IV: DYSLIPIDEMIA / ATHEROSCLEROSIS / THROMBOSIS

1:40 PM - 1:45 PM Chair Introduction
Christie M. Ballantyne, MD
1:45 PM - 2:15 PM Risk Prediction: Role of Imaging, Biomarkers, and Genetics
Matthew J. Budoff, MD
2:15 PM - 2:35 PM Update on Inflammation and CVD
Brendan M. Everett, MD
2:35 PM - 3:05 PM Post-MI: When to Start Lipid-lowering Therapy and How Low to Go
Pamela B. Morris, MD
3:05 PM - 3:35 PM Company Spotlight Break
3:35 PM - 4:05 PM Stroke Prevention in the Cardiometabolic Patient with Atrial Fibrillation
4:05 PM - 4:45 PM Antithrombotic and Antiplatelet Therapy in the Cardiometabolic Patient
Supported by an educational grant from Janssen Scientific Affairs, LLC
Deepak L. Bhatt, MD, MPH
4:45 PM - 5:10 PM Expert Panel Discussion and Q&A
Moderator: Christie M. Ballantyne, MD
Panel: Deepak L. Bhatt, MD, MPH; Matthew J. Budoff, MD; Robert H. Eckel, MD; Brendan M. Everett, MD; Margo B. Minissian, PhD, ACNP, NEA-BC, FNLA, FAHA; Pamela B. Morris, MD
5:10 PM - 5:15 PM Closing Remarks
Christie M. Ballantyne, MD
5:15 PM - 5:45 PM Break
5:45 PM - 6:45 PM PME or CME Symposium

Sunday, April 18, 2021

Cardiometabolic Risk and COVID-19: Implications and Practice Considerations

Please note all sessions are in Pacific Daylight Time (PDT)
7:25 AM - 7:30 AM

Introduction and Opening Remarks
Robert H. Eckel, MD

7:30 AM - 8:30 AM Impacts of COVID-19 on Cardiometabolic Risk
  1. COVID-19 & Obesity
    Carl J. Lavie, MD
  2. COVID-19 & Cardiovascular disease
    Clyde W. Yancy, MD, MSc, MACP
  3. COVID-19 & Diabetes
    Jay H. Shubrook, DO, FACOFP, FAAFP
8:30 AM - 9:20 AM Challenging Cases & Expert Panel Discussion: COVID-19 and Cardiometabolic Diseases
Moderator: Robert H. Eckel, MD
Panelists: Carl J. Lavie, MD; Margo B. Minissian, PhD, ACNP, NEA-BC, FNLA, FAHA; Ileana L. Piña, MD; Jay H. Shubrook,DO, FACOFP, FAAFP; Clyde W. Yancy, MD, MSc, MACP
9:20 AM - 10:40 AM Telemedicine in Cardiometabolic Health: The Good, The Bad, and The Ugly
  1. Improving the Management of Obesity with Telemedicine
    Bartolome Burguera, MD, PhD
  2. Telemedicine and Hypertension Assessment and Management
    Daichi Shimbo, MD
  3. Telemedicine and Glucose Monitoring
  4. Optimizing Reimbursement in Telemedicine
    Ahmed M. Soliman, MD
10:40 AM - 11:10 AM Interactive Panel Discussion: Optimizing Telemedicine to Meet Immediate and Long-term Demands in the COVID-19 Era
Moderator: Robert H. Eckel, MD
Panelists: Bartolome Burguera, MD, PhD; Daichi Shimbo, MD; Ahmed M. Soliman, MD
11:10 AM - 11:15 AM Closing Remarks
Robert H. Eckel, MD